摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-Fmoc-4-(hydroxymethyl)piperidine | 1072502-03-4

中文名称
——
中文别名
——
英文名称
1-Fmoc-4-(hydroxymethyl)piperidine
英文别名
9H-fluoren-9-ylmethyl 4-(hydroxymethyl)piperidine-1-carboxylate
1-Fmoc-4-(hydroxymethyl)piperidine化学式
CAS
1072502-03-4
化学式
C21H23NO3
mdl
MFCD02094489
分子量
337.419
InChiKey
YYTSXYVXBGQKCP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    519.3±23.0 °C(Predicted)
  • 密度:
    1.213±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    25
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    49.8
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-Acetoxymethyl-2-(benzyloxycarbonylamino)-acetamide 、 1-Fmoc-4-(hydroxymethyl)piperidine对甲苯磺酸 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 以60.5 %的产率得到
    参考文献:
    名称:
    [EN] LIGAND-DRUG CONJUGATE OF CAMPTOTHECIN ANALOGS, INTERMEDIATES, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF
    [FR] CONJUGUÉ LIGAND-MÉDICAMENT D'ANALOGUES DE CAMPTOTHÉCINE, INTERMÉDIAIRES, SON PROCÉDÉ DE PRÉPARATION, COMPOSITION PHARMACEUTIQUE ET SON APPLICATION
    摘要:
    Provided are conjugates of novel camptothecin analogs with a cell binding molecule of formula (I). It also provides methods of making the conjugates of camptothecin analogs to a cell-binding agent, as well as methods of application the conjugates in targeted treating of cancer.
    公开号:
    WO2023207773A1
  • 作为产物:
    描述:
    4-哌啶甲醇9-芴甲基-N-琥珀酰亚胺基碳酸酯1,4-二氧六环 为溶剂, 反应 16.0h, 以96%的产率得到1-Fmoc-4-(hydroxymethyl)piperidine
    参考文献:
    名称:
    Efficient loading of primary alcohols onto a solid phase using a trityl bromide linker
    摘要:
    The Letter describes an improved, rapid and mild strategy for the loading of primary alcohols onto a polystyrene trityl resin via a highly reactive trityl bromide linker. This protocol facilitates an efficient resin loading even of acid-sensitive or heat-labile alcohols, which otherwise require expensive or non-commercial resin types. Secondary alcohols were only attached in moderate to low yields, while attempts to load a tertiary alcohol expectedly failed. Importantly, selective attachment of diols via a primary alcohol group in the presence of more hindered alcohol groups proved possible. The effects of activation time and reagent excess as well as alcohol structure were investigated. This improved method provides a convenient access to O-linked resin-bound N-Fmoc-protected amino alcohols that may be employed in SPS of peptides with C-terminal alcohol functionalities. In the case of a sensitive alcohol containing an activated aziridine functionality, the use of the trityl bromide linker proved superior to a recently described silver triflate-assisted trityl chloride resin-based Procedure. (C) 2008 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2008.07.130
点击查看最新优质反应信息

文献信息

  • [EN] LIBRARIES OF DIVERSE MACROCYCLIC COMPOUNDS AND METHODS OF MAKING AND USING THE SAME<br/>[FR] BIBLIOTHÈQUES DE DIVERS COMPOSÉS MACROCYCLIQUES, LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION
    申请人:CYCLENIUM PHARMA INC
    公开号:WO2017197488A1
    公开(公告)日:2017-11-23
    The present disclosure relates to novel macrocyclic compounds and libraries thereof that are useful as research tools for drug discovery efforts. This disclosure also relates to methods of preparing these compounds and libraries and methods of using these libraries, such as in high throughput screening. In particular, these libraries are useful for evaluation of bioactivity at existing and newly identified pharmacologically relevant targets, including G protein-coupled receptors, nuclear receptors, enzymes, ion channels, transporters, transcription factors, protein-protein interactions and nucleic acid-protein interactions. As such, these libraries can be applied to the search for new pharmaceutical agents for the treatment and prevention of a range of medical conditions.
  • Efficient loading of primary alcohols onto a solid phase using a trityl bromide linker
    作者:François Crestey、Lars K. Ottesen、Jerzy W. Jaroszewski、Henrik Franzyk
    DOI:10.1016/j.tetlet.2008.07.130
    日期:2008.10
    The Letter describes an improved, rapid and mild strategy for the loading of primary alcohols onto a polystyrene trityl resin via a highly reactive trityl bromide linker. This protocol facilitates an efficient resin loading even of acid-sensitive or heat-labile alcohols, which otherwise require expensive or non-commercial resin types. Secondary alcohols were only attached in moderate to low yields, while attempts to load a tertiary alcohol expectedly failed. Importantly, selective attachment of diols via a primary alcohol group in the presence of more hindered alcohol groups proved possible. The effects of activation time and reagent excess as well as alcohol structure were investigated. This improved method provides a convenient access to O-linked resin-bound N-Fmoc-protected amino alcohols that may be employed in SPS of peptides with C-terminal alcohol functionalities. In the case of a sensitive alcohol containing an activated aziridine functionality, the use of the trityl bromide linker proved superior to a recently described silver triflate-assisted trityl chloride resin-based Procedure. (C) 2008 Elsevier Ltd. All rights reserved.
  • [EN] LIGAND-DRUG CONJUGATE OF CAMPTOTHECIN ANALOGS, INTERMEDIATES, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF<br/>[FR] CONJUGUÉ LIGAND-MÉDICAMENT D'ANALOGUES DE CAMPTOTHÉCINE, INTERMÉDIAIRES, SON PROCÉDÉ DE PRÉPARATION, COMPOSITION PHARMACEUTIQUE ET SON APPLICATION
    申请人:[en]SHANGHAI MICURX PHARMACEUTICAL CO., LTD.
    公开号:WO2023207773A1
    公开(公告)日:2023-11-02
    Provided are conjugates of novel camptothecin analogs with a cell binding molecule of formula (I). It also provides methods of making the conjugates of camptothecin analogs to a cell-binding agent, as well as methods of application the conjugates in targeted treating of cancer.
查看更多

同类化合物

(S)-2-N-Fmoc-氨基甲基吡咯烷盐酸盐 (2S,4S)-Fmoc-4-三氟甲基吡咯烷-2-羧酸 黎芦碱 鳥胺酸 魏因勒卜链接剂 雷迪帕韦二丙酮合物 雷迪帕韦 雷尼托林 锰(2+)二{[乙酰基(9H-芴-2-基)氨基]氧烷负离子} 达托霉素杂质 赖氨酸杂质4 螺[环戊烷-1,9'-芴] 螺[环庚烷-1,9'-芴] 螺[环己烷-1,9'-芴] 螺-(金刚烷-2,9'-芴) 藜芦托素 荧蒽 反式-2,3-二氢二醇 草甘膦-FMOC 英地卡胺 苯芴醇杂质A 苯并[a]芴酮 苯基芴胺 苯(甲)醛,9H-芴-9-亚基腙 芴甲氧羰酰胺 芴甲氧羰酰基高苯丙氨酸 芴甲氧羰酰基肌氨酸 芴甲氧羰酰基环己基甘氨酸 芴甲氧羰酰基正亮氨酸 芴甲氧羰酰基D-环己基甘氨酸 芴甲氧羰酰基D-Β环己基丙氨酸 芴甲氧羰酰基-O-三苯甲基丝氨酸 芴甲氧羰酰基-D-正亮氨酸 芴甲氧羰酰基-6-氨基己酸 芴甲氧羰基-高丝氨酸内酯 芴甲氧羰基-缬氨酸-1-13C 芴甲氧羰基-beta-赖氨酰酸(叔丁氧羰基) 芴甲氧羰基-S-叔丁基-L-半胱氨酸五氟苯基脂 芴甲氧羰基-S-乙酰氨甲基-L-半胱氨酸 芴甲氧羰基-PEG9-羧酸 芴甲氧羰基-PEG8-琥珀酰亚胺酯 芴甲氧羰基-PEG7-羧酸 芴甲氧羰基-PEG4-羧酸 芴甲氧羰基-O-苄基-L-苏氨酸 芴甲氧羰基-O-叔丁酯-L-苏氨酸五氟苯酚酯 芴甲氧羰基-O-叔丁基-D-苏氨酸 芴甲氧羰基-N6-三甲基硅乙氧羰酰基-L-赖氨酸 芴甲氧羰基-L-苏氨酸 芴甲氧羰基-L-脯氨酸五氟苯酯 芴甲氧羰基-L-半胱氨酸 芴甲氧羰基-L-β-高亮氨酸